Y-mAbs Therapeutics Inc Research And Development Day (Virtual) Transcript
Good afternoon, and welcome to the Y-mAbs Therapeutics Virtual R&D Day. (Operator Instructions)
I'd now like to turn the call over to Thomas Gad, President and Founder of Y-mAbs Therapeutics. Please go ahead, Thomas.
Thank you, Sarah, and thank you, everyone, for joining us today at our third annual R&D Day. We have a very exciting lineup of speakers today, starting with Dr. Oesterheld from Levine in North Carolina, who's going to present on the current treatment landscape of DANYELZA today, followed by Dr. Mora from Barcelona, who's going to show us some exciting those in experience with DANYELZA on patients with high-risk neuroblastoma. We will hear from Dr. Rajah, who is our Chief Medical Officer, how that new dosing experience plays into our strategy with DANYELZA going forward.
And we will hear from Dr. Steen Lisby, our Chief Scientific Officer, on an update on our very exciting platform, SADA; and Claus Moller,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |